Opaleye Management Inc.
Q4 2025 13F Holdings
- Locationboston, MA
- Num holdings
54
- Value ($000)
$757,990
- Date Filed02/17/2026
- Form type13F-HR
- CIK0001595855
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
HARROW HEALTH INC | COM | 415858109 | $191.35M | 25 % | 3,905,000 | ||
LIQUIDIA CORPORATION | COM NEW | 53635D202 | $84.98M | 11 % | 2,435,000 | ||
ETON PHARMACEUTICALS INC | COM | 29772L108 | $48.36M | 6 % | 2,860,000 | ||
RHYTHM PHARMACEUTICALS INC | COM | 76243J105 | $35.32M | 5 % | 330,000 | ||
APOGEE THERAPEUTICS INC | COM | 03770N101 | $29.31M | 4 % | 388,257 | ||
SANUWAVE HEALTH INC | COM | 80303D305 | $29.28M | 4 % | 981,267 | ||
STOKE THERAPEUTICS INC | COM | 86150R107 | $22.06M | 3 % | 695,000 | ||
OCULAR THERAPEUTIX INC | COM | 67576A100 | $19.36M | 3 % | 1,595,000 | ||
SOL GEL TECHNOLOGIES | SHS NEW | M8694L137 | $19.12M | 3 % | 453,739 | ||
CG ONCOLOGY INC | COM | 156944100 | $17.02M | 2 % | 410,000 |
Rows Per Page
10
- 5
- 10
- 20
- 30
- 50
- 100